Bohai Pharmaceuticals (OTC BB:BOPH)

Yantai Bohai Pharmaceuticals Group Co., Ltd. went public via a share exchange on January 5, with Link Resources.

Highlights:

• Bohai is a profitable company principally engaged in the production, manufacturing and distribution of herbal pharmaceuticals based on traditional Chinese medicine in China.
• Bohai’s medicines address common health problems such as rheumatism, rheumatoid arthritis, respiratory diseases, viral infections, gynecological diseases and cardio vascular issues.
• Bohai’s products are sold either by prescription through hospitals or Over the Counter through local pharmacies and retail drug store chains.
• Bohai generated approximately $50.2 million in audited revenues and approximately $8.0 million in audited net earnings for the fiscal year ended June 30, 2009

Source: Business Wire (January 5, 2010)